Methotrexate

Gene-body mass index interactions are associated with methotrexate toxicity in rheumatoid arthritis
Stella Aslibekyan, Jin Sha, David T Redden, Larry W Moreland, James R O'Dell, Jeffrey R Curtis, Ted R Mikuls, Richard J Reynolds, Maria I Danila, S Louis Bridges

Annals of the Rheumatic Diseases Apr 2014, 73 (4) 785-786; DOI: 10.1136/annrheumdis-2013-204263
How dangerous are norovirus infections in patients with rheumatic diseases treated with biologics and DMARDs? Follow-up on a local outbreak and comparison with a control cohort
Christoph Fiehn, Nikolaus Miehle

Annals of the Rheumatic Diseases Apr 2014, 73 (4) 786-787; DOI: 10.1136/annrheumdis-2013-204437
Adalimumab, a human anti-TNF monoclonal antibody, outcome study for the prevention of joint damage in Japanese patients with early rheumatoid arthritis: the HOPEFUL 1 study
Tsutomu Takeuchi, Hisashi Yamanaka, Naoki Ishiguro, Nobuyuki Miyasaka, Masaya Mukai, Tsukasa Matsubara, Shoji Uchida, Hideto Akama, Hartmut Kupper, Vipin Arora, Yoshiya Tanaka

Annals of the Rheumatic Diseases Mar 2014, 73 (3) 536-543; DOI: 10.1136/annrheumdis-2012-202433
Five-year outcomes of probable rheumatoid arthritis treated with methotrexate or placebo during the first year (the PROMPT study)
Jill van Aken, Lotte Heimans, Henrike Gillet-van Dongen, Karen Visser, H Karel Ronday, Irene Speyer, André J Peeters, Tom W J Huizinga, Cornelia F Allaart

Annals of the Rheumatic Diseases Feb 2014, 73 (2) 396-400; DOI: 10.1136/annrheumdis-2012-202967
Effect of tumour necrosis factor blockers on radiographic progression of psoriatic arthritis: a systematic review and meta-analysis of randomised controlled trials
Radjiv Goulabchand, Gaël Mouterde, Thomas Barnetche, Cédric Lukas, Jacques Morel, Bernard Combe

Annals of the Rheumatic Diseases Feb 2014, 73 (2) 414-419; DOI: 10.1136/annrheumdis-2012-202641
The role of methotrexate co-medication in TNF-inhibitor treatment in patients with psoriatic arthritis: results from 440 patients included in the NOR-DMARD study
Karen Minde Fagerli, Elisabeth Lie, Désirée van der Heijde, Marte Schrumpf Heiberg, Åse Stavland Lexberg, Eric Rødevand, Synøve Kalstad, Knut Mikkelsen, Tore K Kvien

Annals of the Rheumatic Diseases Jan 2014, 73 (1) 132-137; DOI: 10.1136/annrheumdis-2012-202347
Head-to-head comparison of subcutaneous abatacept versus adalimumab for rheumatoid arthritis: two-year efficacy and safety findings from AMPLE trial
Michael Schiff, Michael E Weinblatt, Robert Valente, Désirée van der Heijde, Gustavo Citera, Ayanbola Elegbe, Michael Maldonado, Roy Fleischmann

Annals of the Rheumatic Diseases Jan 2014, 73 (1) 86-94; DOI: 10.1136/annrheumdis-2013-203843
Impact of the European paediatric legislation in paediatric rheumatology: past, present and future
Nicolino Ruperto, Richard Vesely, Agnes Saint-Raymond, Alberto Martini, for the Paediatric Rheumatology International Trials Organisation (PRINTO)

Annals of the Rheumatic Diseases Dec 2013, 72 (12) 1893-1896; DOI: 10.1136/annrheumdis-2013-204168
The immunogenicity of anti-TNF therapy in immune-mediated inflammatory diseases: a systematic review of the literature with a meta-analysis
Sandra Garcês, Jocelyne Demengeot, Elizabeth Benito-Garcia

Annals of the Rheumatic Diseases Dec 2013, 72 (12) 1947-1955; DOI: 10.1136/annrheumdis-2012-202220
Tabalumab, an anti-BAFF monoclonal antibody, in patients with active rheumatoid arthritis with an inadequate response to TNF inhibitors
Mark C Genovese, Roy M Fleischmann, Maria Greenwald, Julie Satterwhite, Melissa Veenhuizen, Li Xie, Pierre-Yves Berclaz, Stephen Myers, Olivier Benichou

Annals of the Rheumatic Diseases Sep 2013, 72 (9) 1461-1468; DOI: 10.1136/annrheumdis-2012-202775

Main menu

Methotrexate

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Methotrexate

Pages